Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) plummeted -4.73 percent and ended the day at $1.61. The Average Volume of the company is 1.55 Million and P/E (price to earnings) ratio is 0, while Forward P/E ratio is 0.
H.C. Wainwright Initiated its coverage for Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) in a note sent to investors on 20-Jan-17. The research firm Initiated the stock to Buy. Moreover, FBR Capital issued Initiated rating for the stock on 16-Mar-15.
The highest price BLPH stock touched in the last 12 month was $4.58 and the lowest price it hit in the same period was $0.43. The stock has a Return on Assets of -91.7 percent, Return on Investment of 0 percent and a Return on Equity of -118 percent. The company’s market cap is $50.96 Million.
Price Target is an important factor while doing analysis of a stock. According to 1 analysts, Price Target for Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) may hit a high of $5. The average and low price target for the stock are $5 and $5, respectively.
Now we look at the Moving Averages, the 200-day is 28.81, the 50-day is 86.82 and the 20-day is 33.43. Moving averages are used as a strong indicator for technical stock analysis and it helps investors in figuring out where the stock has been and also help in determining where it may be possibly heading.
When we look at the recommendation trends, the stock presently has an average brokerage recommendation of 0.2. Out of 1 brokerage recommendations, 0 gave a Strong Buy, 1 issued a Buy, 0 issued Hold, 0 rated Under-perform and 0 issued a Sell.
Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) performance during the last one year Degraded -41.45 percent, while its year to date (YTD) performance showed a Positive trend of 209.62 percent. The stock Jumped 15 percent over the past six months. The stock’s quarterly performance indicates a Positive momentum of 209.62 percent, whereas its last one month trend is Optimistic with 137.46 percent. Its weekly performance showed upward trend of 21.05 percent.
Profitability analysis helps a great deal in making investment decision. Net profit margin of the company was recorded at 0 percent, operating profit margin was 0 percent, whereas gross profit margin stands at 0 percent. Beta factor was calculated at 0.
Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) has 30.14 Million shares outstanding and 28.36 Million shares were floated in market. The short ratio in the company’s stock is documented at 0.98 and the short float is around of 5.36%. The stock’s average true range of stands at 0.21, while the relative strength index is 63.55.
Liquidity ratios helps investors to determine a company’s ability to pay off its debts. For the most recent quarter, quick ratio was 3.7, current ratio was 3.7, LT Debt/Equity ratio was 0 and Total Debt/Equity ratio was 0.